Immunocytology in the assessment of patients with asymptomatic hematuria

World Journal of Urology

Volumn 26, Issue 1, 2008, Pages 31-37

  Schmitz Drager B J ^a   Tirsar, L A ^a   Schmitz Drager C ^a   Dorsam J ^a   Mellan, Z ^a   Bismarck, E ^a   Ebert, T ^a  

^a EuromedClinic ^*  (Germany)

Author keywords

Bladder cancer; Diagnosis; Gross hematuria; Immunocytology; Microhematuria

Indexed keywords

BIOLOGICAL MARKER;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FEMALE; HEMATURIA; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PROGNOSIS; RETROSPECTIVE STUDY; URETEROSCOPY; URINALYSIS; URINE;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEMATURIA; HUMANS; IMMUNOHISTOCHEMISTRY; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; URETEROSCOPY; URINALYSIS;

EID: 39349116584     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-007-0228-x     Document Type: Article

References (17)

1. Yun EJ, Meng MV, Carroll PR (2004) Evaluation of the patient with hematuria. Med Clin North Am 88:329-343
2. Oosterlinck W, v d Meijden A, Sylvester R et al (2007) Guidelines on TaT1 (non-muscle invasive) bladder cancer. In: Aus G, Hanus T, Irani J et al (eds) European association of urology: Guidelines, 2007 edn, pp 3-17
3. Khan MA, Shaw G, Paris AM (2002) Is microscopic haematuria a urological emergency? BJU Int 90:355-357
4. Schmitz-Dräger BJ, Beiche B, Tirsar L-A et al (2006) Immunocytology in the assessment of patients with asymptomatic microhematuria. Eur Urol 51:1582-1588
5. Lokeshwar VB, Habuchi T, Grossman HB et al 2005 Bladder tumor markers beyond cytology: International consensus panel on bladder tumor markers. Urology 66(6 Suppl 1):35-63
6. Mian C, Pycha A, Wiener H et al (1999) Immunocyt: A new tool for detecting transitional cell cancer of the urinary tract. J Urol 161:1486-1489
7. Sobin DH, Wittekind C (eds) (2002) TNM classification of malignant tumours. 6th edn. Wiley-Liss, New York, pp 199-202
8. Sauter G, Algaba F, Amin M et al (2004) Tumours of the urinary system: non-invasive urothelial neoplasias In: Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds) World health organization classification of tumours. Pathology and genetics. Tumours of the urinary system and male genital organs. IARC, Lyon
9. Goebell P, Groshen S, Schmitz-Dräger BJ et al (2007) Good clinical practise guidelines for marker development. World J Urol (in press)
10. Chong TW, Cheng C (1999) The role of the bladder tumour antigen test in the management of gross haematuria. Singapore Med J 40:578-580
11. Oge O, Kozaci D, Gemalmaz H (2002) The BTA stat test is nonspecific for hematuria: An experimental hematuria model. J Urol 167:1318-1319
12. Sarosdy MF, Kahn PR, Ziffer MD, Love WR, Barkin J, Abara EO, Jansz K, Bridge JA, Johansson SL, Persons DL, Gibson JS (2006) Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria. J Urol 176:44-47
13. Grossman HB, Messing E, Soloway M, Tomera K, Katz G, Berger Y, Shen Y (2005) Detection of bladder cancer using a point-of-care proteomic assay. JAMA 293:810-816
14. Schmitz-Dräger BJ, Tirsar L-A, Schmitz-Dräger C, Dörsam J, Bismarck E, Ebert T (2007) Immunocytology in the assessment of patients with gross hematuria. Br J Urol (Epub ahead of print)
15. Rodgers M, Nixon J, Hempel S, Aho T, Kelly J, Neal D, Duffy S, Ritchie G, Kleijnen J, Westwood M (2006) Diagnostic tests and algorithms used in the investigation of haematuria: Systematic reviews and economic evaluation. Health Technol Assess 10:iIi-iv, xi-259
16. Lotan Y, Shariat S, Malats N (2007) Screening for bladder cancer - an option? World J Urol
17. Madep R, Messing EM (2007) Long term outcome of home dip-stick testing for hematuria. World J Urol (in press)